EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Akkermansia muciniphila in traumatic brain injury: from gut dysbiosis to microglial modulation via sphingolipid metabolism

Lin Liu, Fang Wang, Yinghui Li

Frontiers in Microbiology · 20.11.2026 · 17

DOI: 10.3389/fmicb.2026.1967134 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 20.11.2026. Verfasst von Lin Liu und 2 weiteren Autor:innen. Die Arbeit nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Traumatic brain injury (TBI) remains a leading cause of long-term disability worldwide, yet disease-modifying therapies targeting chronic neuroinflammation remain scarce. Emerging evidence has positioned the gut microbiome as a critical modulator of post-TBI outcomes, with Akkermansia muciniphila emerging as a particularly promising candidate. Preclinical studies demonstrate that Akkermansia supplementation alleviates persistent microglial activation and improves cognitive function in TBI models. Mechanistically, multi-omics analyses reveal that Akkermansia effectively blocks TBI-induced elevation of sphingolipid metabolism, a pathway closely linked to sustained microglial reactivity. The bacterium modulates microglial function through both indirect pathways involving short-chain fatty acids and tryptophan metabolites, and direct interactions via outer membrane proteins and extracellular vesicles. This review synthesizes current evidence indicating that, in preclinical TBI models, A. muciniphila is a candidate neuroimmune modulator that may bridge gut dysbiosis to microglial dysfunction through sphingolipid metabolism, thereby offering a hypothesis-generating preclinical rationale for mitigating the chronic consequences of traumatic brain injury.

Zitieren

APA

Liu, L., Wang, F., & Li, Y. (2026). Akkermansia muciniphila in traumatic brain injury: from gut dysbiosis to microglial modulation via sphingolipid metabolism. Frontiers in Microbiology, 17. https://doi.org/10.3389/fmicb.2026.1967134

Vancouver

Liu L, Wang F, Li Y. Akkermansia muciniphila in traumatic brain injury: from gut dysbiosis to microglial modulation via sphingolipid metabolism. Frontiers in Microbiology. 2026;17. doi:10.3389/fmicb.2026.1967134

BibTeX
@article{Liu2026,
  author = {Liu, Lin and Wang, Fang and Li, Yinghui},
  title = {Akkermansia muciniphila in traumatic brain injury: from gut dysbiosis to microglial modulation via sphingolipid metabolism},
  journal = {Frontiers in Microbiology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fmicb.2026.1967134}
}
Kostenlos starten →